[1]
|
Roehlen, N., Crouchet, E. and Baumert, T.F. (2020) Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives. Cells, 9, Article No. 875. https://doi.org/10.3390/cells9040875
|
[2]
|
Yao, L., Hu, X., Dai, K., et al. (2022) Mesenchymal Stromal Cells: Promising Treatment for Liver Cirrhosis. Stem Cell Research & Therapy, 13, Article No. 308. https://doi.org/10.1186/s13287-022-03001-z
|
[3]
|
Huang, D.Q., Terrault, N.A., Tacke, F., et al. (2023) Global Epidemiology of Cirrhosis—Aetiology, Trends and Predictions. Nature Reviews Gastroenterology & Hepatology, 20, 388-398. https://doi.org/10.1038/s41575-023-00759-2
|
[4]
|
D’Amico, G., Garcia-Tsao, G. and Pagliaro, L. (2006) Natural History and Prognostic Indicators of Survival in Cirrhosis: A Systematic Review of 118 Studies. Journal of Hepatology, 44, 217-231.
https://doi.org/10.1016/j.jhep.2005.10.013
|
[5]
|
林德照, 郑建建, 林镯, 等. 血浆MiR-125a-5p在肝纤维化患者中的表达及意义[J]. 中国卫生检验杂志, 2014, 24(3): 380-382.
|
[6]
|
Zhou, J., Wang, L., Cui, Y., et al. (2021) MiR-125a-5p-Targeted Regulation of TRA2β Expression Inhibits Proliferation and Metastasis of Hepatocellular Carcinoma Cells. American Journal of Translational Research, 13, 14074-14080.
|
[7]
|
Xu, X., Tao, Y., Niu, Y., et al. (2019) MiR-125a-5p Inhibits Tumorigenesis in Hepatocellular Carcinoma. Aging (Albany NY), 11, 7639-7662. https://doi.org/10.18632/aging.102276
|
[8]
|
Lin, L., Chen, X., Sun, X., et al. (2022) MiR-125b-5p Is Targeted by Curcumin to Regulate the Cellular Antioxidant Capacity. Free Radical Research, 56, 640-650. https://doi.org/10.1080/10715762.2022.2162393
|
[9]
|
Cai, Q., Chen, F., Xu, F., et al. (2020) Epigenetic Silencing of MicroRNA-125b-5p Promotes Liver Fibrosis in Nonalcoholic Fatty Liver Disease via Integrin α8-Mediated Activation of RhoA Signaling Pathway. Metabolism, 104, Article ID: 154140. https://doi.org/10.1016/j.metabol.2020.154140
|
[10]
|
Ma, C., Wang, C., Zhang, Y., et al. (2023) Phillygenin Inhibited M1 Macrophage Polarization and Reduced Hepatic Stellate Cell Activation by Inhibiting Macrophage Exosomal MiR-125b-5p. Biomedicine & Pharmacotherapy, 159, Article ID: 114264. https://doi.org/10.1016/j.biopha.2023.114264
|
[11]
|
Giray, B.G., Emekdas, G., Tezcan, S., et al. (2014) Profiles of Serum MicroRNAs; MiR-125b-5p and MiR223-3p Serve as Novel Biomarkers for HBV-Positive Hepatocellular Carcinoma. Molecular Biology Reports, 41, 4513-4519.
https://doi.org/10.1007/s11033-014-3322-3
|
[12]
|
Jin, F.E., Xie, B., Xian, H.Z., et al. (2021) Knockdown of MiR-125b-5p Inhibits the Proliferation and Invasion of Gastric Carcinoma Cells by Targeting RYBP. The Kaohsiung Journal of Medical Sciences, 37, 863-871.
https://doi.org/10.1002/kjm2.12425
|
[13]
|
Bourne, P.E. (2021) Is “Bioinformatics” Dead? PLOS Biology, 19, e3001165.
https://doi.org/10.1371/journal.pbio.3001165
|
[14]
|
Muriel, P., López-Sánchez, P. and Ramos-Tovar, E. (2021) Fructose and the Liver. International Journal of Molecular Sciences, 22, Article No. 6969. https://doi.org/10.3390/ijms22136969
|
[15]
|
Cho, Y.E., Kim, D.K., Seo, W., et al. (2021) Fructose Promotes Leaky Gut, Endotoxemia, and Liver Fibrosis through Ethanol-Inducible Cytochrome P450-2E1-Mediated Oxidative and Nitrative Stress. Hepatology, 73, 2180-2195.
https://doi.org/10.1002/hep.30652
|
[16]
|
Beyoğlu, D., Huang, P., Skelton-Badlani, D., et al. (2023) Metabolic Hijacking of Hexose Metabolism to Ascorbate Synthesis Is the Unifying Biochemical Basis of Murine Liver Fibrosis. Cells, 12, Article No. 485.
https://doi.org/10.3390/cells12030485
|
[17]
|
Federico, A., Rosato, V., Masarone, M., et al. (2021) The Role of Fructose in Non-Alcoholic Steatohepatitis: Old Relationship and New Insights. Nutrients, 13, Article No. 1314. https://doi.org/10.3390/nu13041314
|
[18]
|
Bi, Y., Liu, S., Qin, X., et al. (2023) FUNDC1 Interacts with GPx4 to Govern Hepatic Ferroptosis and Fibrotic Injury through a Mitophagy-Dependent Manner. Journal of Advanced Research, 55, 45-60.
https://doi.org/10.1016/j.jare.2023.02.012
|
[19]
|
Loomba, R., Friedman, S.L. and Shulman, G.I. (2021) Mechanisms and Disease Consequences of Nonalcoholic Fatty Liver Disease. Cell, 184, 2537-2564. https://doi.org/10.1016/j.cell.2021.04.015
|
[20]
|
Jeon, S. and Carr, R. (2020) Alcohol Effects on Hepatic Lipid Metabolism. Journal of Lipid Research, 61, 470-479.
https://doi.org/10.1194/jlr.R119000547
|
[21]
|
Charni-Natan, M., Aloni-Grinstein, R., Osher, E., et al. (2019) Liver and Steroid Hormones—Can a Touch of P53 Make a Difference? Frontiers in Endocrinology (Lausanne), 10, Article No. 374.
https://doi.org/10.3389/fendo.2019.00374
|
[22]
|
韦平和, 李谦, 邢为藩. 大肠杆菌N-乙酰神经氨酸裂合酶基因的组成型高效表达[J]. 中国药科大学学报, 2000(1): 68-71.
|
[23]
|
Zhang, M., Lin, Y., Chen, R., et al. (2023) Ghost Messages: Cell Death Signals Spread. Cell Communication and Signaling, 21, Article No. 6. https://doi.org/10.1186/s12964-022-01004-0
|
[24]
|
Wen, X.Y., Tarailo-Graovac, M., Brand-Arzamendi, K., et al. (2018) Sialic Acid Catabolism by N-Acetylneuraminate Pyruvate Lyase Is Essential for Muscle Function. JCI Insight, 3, e122373. https://doi.org/10.1172/jci.insight.122373
|
[25]
|
居蓉. 雄激素及糖皮质激素代谢关键基因多态性与多囊卵巢综合征遗传易感性的关联研究[D]: [博士学位论文]. 南京: 南京医科大学, 2016.
|
[26]
|
Martínez-García, M.A., San-Millán, J.L. and Escobar-Morreale, H.F. (2012) The R453Q and D151A Polymorphisms of Hexose-6-Phosphate Dehydrogenase Gene (H6PD) Influence the Polycystic Ovary Syndrome (PCOS) and Obesity. Gene, 497, 38-44. https://doi.org/10.1016/j.gene.2012.01.047
|
[27]
|
Chedid, M.F., Do Nascimento, F.V., De Oliveira, F.S., et al. (2019) Interaction of HSD11B1 and H6PD Polymorphisms in Subjects with Type 2 Diabetes Are Protective Factors against Obesity: A Cross-Sectional Study. Diabetology & Metabolic Syndrome, 11, Article No. 78. https://doi.org/10.1186/s13098-019-0474-2
|
[28]
|
Martin, J.E., Assassi, S., Diaz-Gallo, L.M., et al. (2013) A Systemic Sclerosis and Systemic Lupus Erythematosus Pan-Meta-GWAS Reveals New Shared Susceptibility Loci. Human Molecular Genetics, 22, 4021-4029.
https://doi.org/10.1093/hmg/ddt248
|
[29]
|
Zou, C., Lyu, Y., Jiang, J., et al. (2020) Use of Peripheral Blood Transcriptomic Biomarkers to Distinguish High-Grade Cervical Squamous Intraepithelial Lesions from Low-Grade Lesions. Oncology Letters, 20, 2280-2290.
https://doi.org/10.3892/ol.2020.11779
|
[30]
|
Guo, L. and Liu, D. (2022) Identification of RFX5 as Prognostic Biomarker and Associated with Immune Infiltration in Stomach Adenocarcinoma. European Journal of Medical Research, 27, Article No. 164.
https://doi.org/10.1186/s40001-022-00794-w
|
[31]
|
Zhao, Y., Xie, X., Liao, W., et al. (2017) The Transcription Factor RFX5 Is a Transcriptional Activator of the TPP1 Gene in Hepatocellular Carcinoma. Oncology Reports, 37, 289-296. https://doi.org/10.3892/or.2016.5240
|